Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Neuroimaging education in psychiatric training
    Published on 2024-07-18
    12 months ago
  • Transcranial photobiomodulation: an emerging therapeutic method to enhance brain bioenergetics
    Published on 2024-07-18
    12 months ago
  • Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity
    Published on 2024-07-18
    12 months ago
  • Is treatment-resistant schizophrenia a neuroimmune condition? Meta-analytic evidence from magnetic resonance spectroscopy
    Published on 2024-07-18
    12 months ago
  • Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters
    Published on 2024-07-17
    12 months ago
  • Rewiring the brain: Inflammation’s impact on glutamate and neural networks in depression
    Published on 2024-07-17
    12 months ago
  • Virtual reality exposure therapy advances and potential for clinical and experimental use
    Published on 2024-07-17
    12 months ago
« Previous 1 … 34 35 36 37 38 … 143 Next »
Journal of Psychopharmacology
  • Postpartum psychosis: A proposed treatment algorithm
    Published on 2023-07-29
    2 years ago
  • Association of cannabis use with neurocognition in adolescents with bipolar disorder
    Published on 2023-07-27
    2 years ago
  • Ketamine-induced changes in resting state connectivity, 2 h after the drug administration in patients with remitted depression
    Published on 2023-07-26
    2 years ago
  • Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Published on 2023-07-19
    2 years ago
  • Modafinil: A closer look at its theoretical toxicological potential
    Published on 2023-07-12
    2 years ago
  • Science, safety and education: Informing the psychedelic treatment of psychiatric disorders
    Published on 2023-07-08
    2 years ago
  • Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
    Published on 2023-07-05
    2 years ago
« Previous 1 … 34 35 36 37 38 … 124 Next »
European Neuropsychopharmacology
  • Psychomotor slowing in schizophrenia is associated with cortical thinning of primary motor cortex: A three cohort structural magnetic resonance imaging study
    Published on 2023-09-16
    2 years ago
  • Association of polygenic risk for bipolar disorder with resting-state network functional connectivity in youth with and without bipolar disorder
    Published on 2023-09-16
    2 years ago
  • Is it stress or is it the hormones? Perinatal depression in fathers
    Published on 2023-09-12
    2 years ago
  • A central serotonin regulating gene polymorphism (TPH2) determines vulnerability to acute tryptophan depletion-induced anxiety and ventromedial prefrontal threat reactivity in healthy young men
    Published on 2023-09-04
    2 years ago
  • Exploring the potential of Esketamine in the treatment of bipolar depression
    Published on 2023-09-04
    2 years ago
  • The prevalence and correlates of suicidal ideation in Chinese psychiatric patients during the fifth wave of COVID-19 in Hong Kong
    Published on 2023-09-02
    2 years ago
  • Social cognition and psychosocial functioning in schizophrenia and bipolar disorder: Theory of mind as a key to understand schizophrenia dysfunction
    Published on 2023-09-02
    2 years ago
« Previous 1 … 34 35 36 37 38 … 144 Next »

   Pharma Pub